Literature DB >> 593431

Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycol-sulphate in the rat brain.

M Nielsen, C Braestrup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 593431     DOI： 10.1007/bf00505084

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  33 in total

1.  INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

Authors:  J GLOWINSKI; J AXELROD
Journal:  Nature       Date:  1964-12-26       Impact factor: 49.962

2.  The influence of desipramine and amitriptyline on the accumulation of [3-H]noradrenaline and its two major metabolites formed from [3-H]tyrosine in the rat brain.

Authors:  M Nielsen
Journal:  J Pharm Pharmacol       Date:  1975-03       Impact factor: 3.765

3.  Estimation of noradrenaline and its major metabolites synthesized from [3H] tyrosine in the rat brain.

Authors:  M Nielsen
Journal:  J Neurochem       Date:  1976-08       Impact factor: 5.372

4.  Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain.

Authors:  J Schubert; H Nybäck; G Sedvall
Journal:  J Pharm Pharmacol       Date:  1970-02       Impact factor: 3.765

5.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

6.  Effects of noradrenaline pump blockers on its uptake by synaptosomes from several brain regions; additional evidence for dopamine terminals in the frontal cortex.

Authors:  R F Squires
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

7.  Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats.

Authors:  C Braestrup; M Nielsen
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

8.  The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.

Authors:  C Braestrup; H Andersen; A Randrup
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

9.  Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.

Authors:  B B Brodie; E Costa; A Groppetti; C Matsumoto
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

10.  Tricyclic antidepressants: evidence for an intraneuronal site of action.

Authors:  W D Reid; F J Stefano; S Kurzepa; B B Brodie
Journal:  Science       Date:  1969-04-25       Impact factor: 47.728
View more
  6 in total

Review 1.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

2.  Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.

Authors:  D S Charney; A Breier; P I Jatlow; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.

Authors:  R B Rastogi; R L Singhal; Y D Lapierre
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Chronic and acute administration of typical and atypical antidepressants on activity of brain noradrenaline systems in the rat thiopentone anaesthesia model.

Authors:  S T Mason; A Angel
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.

Authors:  M Nielsen; C Braestrup
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

6.  Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems.

Authors:  S T Mason; A Angel
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.